[1]
|
Sun, J., Singh, P., Österlund, J., et al. (2021) Hyperglycaemia-Associated Caspase-3 Predicts Diabetes and Coronary Artery Disease Events. Journal of Internal Medicine, 290, 855-865. https://doi.org/10.1111/joim.13327
|
[2]
|
Krishnan, P., Tarricone, A., Gee, A., et al. (2022) Analysis of Interwoven Nitinol Stenting for the Treatment of Critical Limb Ischemia: Outcomes from an Average 3-Year Follow-Up Period. An-giology, 73, 407-412.
https://doi.org/10.1177/00033197211043406
|
[3]
|
de Boer, S.W., de Vries, J.P.P.M., Werson, D.A., et al. (2019) Drug Coated Balloon Supported Supera Stent versus Supera Stent in Intermediate and Long-Segment Lesions of the Su-perficial Femoral Artery: 2-Year Results of the RAPID Trial. The Journal of Cardiovascular Surgery (Torino), 60, 679-685.
https://doi.org/10.23736/S0021-9509.19.11109-3
|
[4]
|
Müller-Bühl, U., Strecker, E.P., Göttmann, D., et al. (2000) Improvement in Claudication after Angioplasty of Distal Ostial Collateral Stenosis in Patients with Long-Segment Occlu-sion of the Femoral Artery. CardioVascular and Interventional Radiology, 23, 447-451. https://doi.org/10.1007/s002700010102
|
[5]
|
Ren, W., Xue, J., Zhao, T., et al. (2023) Recanalization of Chronic Long-Segment Occlusion of the Internal Carotid Artery with Endovascular and Hybrid Surgery. Scientific Reports, 13, Article No. 17026.
https://doi.org/10.1038/s41598-023-44406-x
|
[6]
|
Karathanos, C., Spanos, K., Saleptsis, V., et al. (2015) Sin-gle-Center Experience with Remote Endarterectomy for the Treatment of Long-Segment Superficial Femoral Artery Oc-clusion: Long-Term Results. Vascular and Endovascular Surgery, 49, 250-255. https://doi.org/10.1177/1538574415617555
|
[7]
|
Yuan, L., Bao, J., Zhao, Z., et al. (2014) Endovascular Therapy for Long-Segment Atherosclerotic Aortoiliac Occlusion. Journal of Vascular Surgery, 59, 663-668. https://doi.org/10.1016/j.jvs.2013.09.005
|
[8]
|
Dick, P., Wallner, H., Sabeti, S., et al. (2009) Balloon Angioplasty versus Stenting with Nitinol Stents in Intermediate Length Superficial Femoral Artery Lesions. Catheterization and Car-diovascular Interventions, 74, 1090-1095.
https://doi.org/10.1002/ccd.22128
|
[9]
|
Krankenberg, H., Schlüter, M., Steinkamp, H.J., et al. (2007) Nitinol Stent Implantation versus Percutaneous Transluminal Angioplasty in Superficial Femoral Artery Lesions up to 10 cm in Length: The Femoral Artery Stenting Trial (FAST). Circulation, 116, 285-292. https://doi.org/10.1161/CIRCULATIONAHA.107.689141
|
[10]
|
Liistro, F., Grotti, S., Porto, I., et al. (2013) Drug-Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery: The DEBATE-SFA Randomized Trial (Drug Eluting Balloon in Peripheral Intervention for the Superficial Femoral Artery). JACC: Cardiovascular Inter-ventions, 6, 1295-1302. https://doi.org/10.1016/j.jcin.2013.07.010
|
[11]
|
de Boer, S.W., van den Heuvel, D.A.F., de Vries-Werson, D.A.B., et al. (2017) Short-Term Results of the RAPID Randomized Trial of the Legflow Paclitax-el-Eluting Balloon with Supera Stenting vs Supera Stenting Alone for the Treatment of Intermediate and Long Superficial Femoral Artery Lesions. Journal of Endovascular Therapy, 24, 783-792. https://doi.org/10.1177/1526602817725062
|
[12]
|
San Norberto, E.M., Flota, C.M., Fidalgo-Domingos, L., et al. (2020) Real-World Results of Supera Stent Implantation for Popliteal Artery Atherosclerotic Lesions: 3-Year Outcome. Annals of Vascular Surgery, 62, 397-405.
https://doi.org/10.1016/j.avsg.2019.06.038
|
[13]
|
Tao, M.J., Gotra, A., Tan, K.T., et al. (2022) SUPERA Stenting in the Common Femoral Artery: Early Experience and Practical Considerations. Vascular and Endovascular Surgery, 56, 357-368.
https://doi.org/10.1177/15385744211068648
|
[14]
|
Gostev, A.A., Osipova, O.O., Cheban, A.V., et al. (2023) Treatment of Long Femoropopliteal Occlusive Lesions with Self-Expanding Interwoven Nitinol Stent: 24 Month Out-comes of the STELLA-SUPERA-SIBERIA Register Trial. Journal of Endovascular Therapy. https://doi.org/10.1177/15266028231170125
|
[15]
|
Van Meirvenne, E., Reyntjens, P. and Tielemans, Y. (2023) Self-Expanding Interwoven Nitinol Stent in Severe Femoropopliteal Arterial Disease. Real Life Results of the Supera Pe-ripheral Stent System®. Acta Chirurgica Belgica, 123, 463-472. https://doi.org/10.1080/00015458.2022.2072457
|
[16]
|
Werk, M., Albrecht, T., Meyer, D.R., et al. (2012) Paclitax-el-Coated Balloons Reduce Restenosis after Femoro-Popliteal Angioplasty: Evidence from the Randomized PACIFIER Trial. Circulation: Cardiovascular Interventions, 5, 831-840.
https://doi.org/10.1161/CIRCINTERVENTIONS.112.971630
|
[17]
|
Werk, M., Langner, S., Reinkensmeier, B., et al. (2008) Inhibition of Restenosis in Femoropopliteal Arteries: Paclitaxel-Coated versus Uncoated Balloon: Femoral Paclitaxel Randomized Pilot Trial. Circulation, 118, 1358-1365.
https://doi.org/10.1161/CIRCULATIONAHA.107.735985
|
[18]
|
Scheinert, D., Duda, S., Zeller, T., et al. (2014) The LEVANT I (Lutonix Paclitaxel-Coated Balloon for the Prevention of Femoropopliteal Restenosis) Trial for Fem-oropopliteal Revascularization: First-in-Human Randomized Trial of Low-Dose Drug-Coated Balloon versus Uncoated Balloon Angioplasty. JACC: Cardiovascular Interventions, 7, 10-19.
https://doi.org/10.1016/j.jcin.2013.05.022
|
[19]
|
Dake, M.D., Ansel, G.M., Jaff, M.R., et al. (2016) Durable Clinical Effectiveness with Paclitaxel-Eluting Stents in the Femoropopliteal Artery: 5-Year Results of the Zilver PTX Randomized Trial. Circulation, 133, 1472-1483.
https://doi.org/10.1161/CIRCULATIONAHA.115.016900
|
[20]
|
Laird, J.R., Schneider, P.A., Tepe, G., et al. (2015) Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal Lesions: 24-Month Results of IN.PACT SFA. Journal of the American College of Cardiology, 66, 2329-2338. https://doi.org/10.1016/j.jacc.2015.09.063
|
[21]
|
Verdoia, M., Zilio, F., Gioscia, R., et al. (2023) Prognostic Impact of Drug-Coated Balloons in Patients with Diabetes Mellitus: A Propensity-Matched Study. American Journal of Cardi-ology, 206, 73-78.
https://doi.org/10.1016/j.amjcard.2023.08.113
|
[22]
|
Rajagopal, R. (2023) Upfront Scoring Balloon Predilatation in Treatment of De-Novo Lesions with Drug-Coated Balloon Angioplasty. Minerva Cardiology and Angiology. https://doi.org/10.23736/S2724-5683.23.06451-7
|
[23]
|
Hicks, K.A., Mahaffey, K.W., Mehran, R., et al. (2018) 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials. Circulation, 137, 961-972. https://doi.org/10.1161/CIRCULATIONAHA.117.033502
|
[24]
|
Nasr, B., Gouailler, F., Marret, O., et al. (2023) Treatment of Long Femoropopliteal Lesions with Self-Expanding Interwoven Nitinol Stent: 24 Month Outcomes of the STELLA-SUPERA Trial. Journal of Endovascular Therapy, 30, 98-105. https://doi.org/10.1177/15266028221075227
|
[25]
|
Chan, Y.C., Cheng, S.W. and Cheung, G.C. (2020) A Midterm Analysis of Patients Who Received Femoropopliteal Helical Interwoven Nitinol Stents. Journal of Vascular Surgery, 71, 2048-2055.
https://doi.org/10.1016/j.jvs.2019.08.284
|
[26]
|
Iida, O., Urasawa, K., Komura, Y., et al. (2019) Self-Expanding Ni-tinol Stent vs Percutaneous Transluminal Angioplasty in the Treatment of Femoropopliteal Lesions: 3-Year Data from the SM-01 Trial. Journal of Endovascular Therapy, 26, 158-167. https://doi.org/10.1177/1526602819826591
|
[27]
|
Brouillet, J., Deloose, K., Goueffic, Y., et al. (2018) Primary Stenting for TASC C and D Femoropopliteal Lesions: One-Year Results from a Multicentric Trial on 203 Patients. The Journal of Cardiovascular Surgery (Torino), 59, 392-404. https://doi.org/10.23736/S0021-9509.16.09282-X
|
[28]
|
Zwakenberg, S.R., de Jong, P.A., Hendriks, E.J., et al. (2020) Intimal and Medial Calcification in Relation to Cardiovascular Risk Factors. PLOS ONE, 15, e0235228. https://doi.org/10.1371/journal.pone.0235228
|
[29]
|
Pan, J., Guo, L., Fang, X., et al. (2022) Protocol of the Evolu-tion Study: A Prospective, Multicenter, Observational Study Evaluating the Effect and Health Economics of Endovascular Treatment in Patients with Moderate and Severe Calcification of Femoropopliteal Artery. Frontiers in Cardiovascular Medicine, 9, Article ID: 1039313.
https://doi.org/10.3389/fcvm.2022.1039313
|
[30]
|
Qin, Q., Chen, L., Ge, L., et al. (2023) Long-Term Clinical Out-comes of Drug-Coated Balloon for the Management of Chronic Total Occlusions. Coronary Artery Disease, 34, 555-561. https://doi.org/10.1097/MCA.0000000000001288
|
[31]
|
Salamaga, S., Stępak, H., Żołyński, M., et al. (2023) Three-Year Real-World Outcomes of Interwoven Nitinol Supera Stent Implantation in Long and Complex Femoropoplit-eal Lesions. Journal of Clinical Medicine, 12, Article No. 4869.
https://doi.org/10.3390/jcm12144869
|
[32]
|
Krishnan, P., Sharma, R., Avadhani, S., et al. (2022) Drug Coated Bal-loon Improves Outcomes of Sub-Optimal Supera Deployment in the Intermediate Term. Scientific Reports, 12, Article No. 21327.
https://doi.org/10.1038/s41598-022-25634-z
|
[33]
|
Werner, M., Paetzold, A., Banning-Eichenseer, U., et al. (2014) Treatment of Complex Atherosclerotic Femoropopliteal Artery Disease with a Self-Expanding Interwoven Nitinol Stent: Midterm Results from the Leipzig SUPERA 500 Registry. Euro Intervention, 10, 861-868. https://doi.org/10.4244/EIJV10I7A147
|
[34]
|
Chan, Y.C., Cheng, S.W., Ting, A.C., et al. (2014) Primary Stenting of Femoropopliteal Atherosclerotic Lesions Using New Helical Interwoven Nitinol Stents. Journal of Vascular Surgery, 59, 384-391.
https://doi.org/10.1016/j.jvs.2013.08.037
|
[35]
|
George, J.C., Rosen, E.S., Nachtigall, J., et al. (2014) SUPERA In-terwoven Nitinol Stent Outcomes in Above-Knee IntErventions (SAKE) Study. Journal of Vascular and Interventional Radiology, 25, 954-961.
https://doi.org/10.1016/j.jvir.2014.03.004
|
[36]
|
Haine, A., Schmid, M.J., Schindewolf, M., et al. (2019) Compari-son between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease. European Journal of Vascular and Endovascular Surgery, 58, 865-873. https://doi.org/10.1016/j.ejvs.2019.09.002
|
[37]
|
Scheinert, D., Werner, M., Scheinert, S., et al. (2013) Treatment of Complex Atherosclerotic Popliteal Artery Disease with a New Self-Expanding Interwoven Nitinol Stent: 12-Month Re-sults of the Leipzig SUPERA Popliteal Artery Stent Registry. JACC: Cardiovascular Interventions, 6, 65-71. https://doi.org/10.1016/j.jcin.2012.09.011
|
[38]
|
Garcia, L., Jaff, M.R., Metzger, C., et al. (2015) Wire-Interwoven Nitinol Stent Outcome in the Superficial Femoral and Proximal Popliteal Arteries: Twelve-Month Results of the SUPERB Trial. Circulation: Cardiovascular Interventions, 8, e000937. https://doi.org/10.1161/CIRCINTERVENTIONS.113.000937
|
[39]
|
Fujihara, M., Takahara, M., Iida, O., et al. (2023) Endovascular Therapy with Interwoven Nitinol Stent Placement after Predilation for Heavily Calcified Fem-oropopliteal Artery Disease: Results of the BURDOCK Study. Journal of Vascular and Interventional Radiology, 34, 1929-1937. https://doi.org/10.1016/j.jvir.2023.07.023
|